In individuals suffering from chronic hepatitis B or C, higher plasma levels of BAFF during the acute phase of the disease have been correlated with disease severity, and the increase in B cell activation could promote the development of the dysregulated autoimmune phenomena associated with HCV [67,73]. The gene discussed is TNFSF13B; the disease is chronic hepatitis B virus infection.